CorVista Health

CorVista Health is a Toronto-based medical technology company founded in 2012, focused on transforming cardiovascular care.

The company offers the CorVista System, a non-invasive, point-of-care diagnostic device that uses AI and machine learning to detect significant coronary artery disease (CAD) and pulmonary hypertension (PH) in just 15 minutes. This innovative system requires no radiation, contrast agents, or exercise, making it accessible and efficient for patients. CorVista Health operates under a "MedTech-as-a-Service" model, providing the CorVista System as a subscription service to healthcare providers, including physicians and clinics in underserved areas. The system is portable, cloud-based, and has received FDA clearance, with a breakthrough designation for its PH add-on. The company's mission is to shorten the path from symptoms to diagnosis, ensuring equitable access to high-quality cardiovascular care for all patients.